|Bid||0.0150 x 0|
|Ask||0.0180 x 0|
|Day's Range||0.0160 - 0.0180|
|52 Week Range||0.0120 - 0.0510|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 15, 2020 - Apr 20, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It's nice to see the Alterity Therapeutics Limited (ASX:ATH) share price up 12% in a week. But spare a thought for the...
Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) has received notification from the Listing Qualifications Department of NASDAQ advising the Company that it is currently non-compliant with NASDAQ's requirement that listed securities maintain a minimum bid price of $US1.00 per share on NASDAQ as outlined in the NASDAQ Listing Rules.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
In 2005 Geoffrey Kempler was appointed CEO of Alterity Therapeutics Limited (ASX:ATH). This report will, first...